Publications by authors named "Kohei Horimoto"

Claim this Profile
A
A Case of Nivolumab-Related Myasthenia Gravis With Pretreatment Positive Anti-Acetylcholine Receptor Antibodies, and a Literature Review.
Minami Takahashi, Junji Kato, Taro Saito, Kohei Horimoto, Yoshiyuki Matsui

Asia Pac J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dermoscopic Findings in Merkel Cell Carcinoma in Japanese patients.
Akinori Matsue, Junji Kato, Kohei Horimoto, Yoshiyuki Matsui, Tokimasa Hida

J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation Between Lymph Node Size and Radioisotope Uptake in Sentinel Nodes of the Popliteal and Inguinal Basins in Melanoma.
Risako Maeda, Junji Kato, Kohei Horimoto, Sayuri Sato, Yoshiyuki Matsui

Int J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late-Onset Large Fixed Erythrodysesthesia Plaque due to Docetaxel.
Takahiko Abe, Tokimasa Hida, Kohei Horimoto, Keiju Kobayashi, Hisashi Uhara

J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion Gene Detection in Driver Mutation-Negative Melanomas Using RNA-Based Anchored Multiplex Polymerase Chain Reaction.
Tokimasa Hida, Masashi Idogawa, Sayuri Sato, Yukiko Kiniwa, Junji Kato, Kohei Horimoto

Pigment Cell Melanoma Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-Interval Dosing of an Immune Checkpoint Inhibitor Following a Complete Response in Melanoma: A Case Report.
Yoshiyuki Matsui, Junji Kato, Tokimasa Hida, Kohei Horimoto, Sayuri Sato

J Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acral Melanoma Successfully Treated With Dacarbazine Following Anti-PD-1 Antibody Therapy: A Case Report and Literature Review.
Iemitsu Matsuda, Junji Kato, Chika Fujie, Kohei Horimoto, Yoshiyuki Matsui

J Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital papillary adenocarcinoma detected human papillomavirus type 42 genome: A case report.
Mizuki Hatakeyama, Sayuri Sato, Kohei Horimoto, Junji Kato, Takafumi Kamiya

J Dermatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extramammary Paget's disease treated with of anti-programmed cell death protein 1 therapy after docetaxel therapy failure.
Midori Narasaki, Junji Kato, Sayuri Sato, Tokimasa Hida, Kohei Horimoto

J Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Severe Immune-Related Adverse Event Under Pembrolizumab Therapy for Discoid Lupus Erythematosus-Related Squamous Cell Carcinoma.
Hidenori Amaike, Hiroyuki Nakamura, Koki Nakamura, Ken Nagahata, Kohei Horimoto

Int J Rheum Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment.
Tomoyuki Minowa, Kenji Murata, Yuka Mizue, Aiko Murai, Munehide Nakatsugawa, Kohei Horimoto

Sci Transl Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan.
Tokimasa Hida, Masashi Idogawa, Junji Kato, Yukiko Kiniwa, Kohei Horimoto

Cancer Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma incidence on the non-weight-bearing areas of the sole.
Kazuki Furudate, Junji Kato, Kohei Horimoto, Sayuri Sato, Tokimasa Hida

J Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated intravascular coagulation induced by the combination therapy of encorafenib and binimetinib in a melanoma case.
Sayuka Komatsu, Kohei Horimoto, Junji Kato, Sayuri Sato, Eri Kobayashi

J Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of CD4 T-cell phenotype in human leukocyte antigen class II-positive acral melanoma.
Nayuha Shogase, Tomoyuki Minowa, Junji Kato, Kohei Horimoto, Sayuri Sato

J Dermatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2.
Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, Taku Yamashita, Koji Araki, Kohei Horimoto

Int J Clin Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the immune microenvironment in the indolent form of primary cutaneous extranodal natural killer/T-cell lymphoma: A case report.
Risako Maeda, Tomoyuki Minowa, Junji Kato, Kohei Horimoto, Sayuri Sato

J Dermatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between tumor thickness and the risk of sentinel node metastasis in acral and non-acral melanoma.
Junji Kato, Tokimasa Hida, Takafumi Kamiya, Kohei Horimoto, Sayuri Sato

Int J Dermatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of degeneration of excision margin tissue using a Colorado MicroDissection Needle: A report of two cases.
Kazuki Furudate, Junji Kato, Kohei Horimoto, Sayuri Sato, Yuna Hosokawa

Australas J Dermatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN).
Anna Kamimura, Yasuhiro Nakamura, Tatsuya Takenouchi, Shigeto Matsushita, Toshikazu Omodaka, Kohei Horimoto

J Dermatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed-onset abscopal effect after palliative radiotherapy for acral melanoma treated with anti-PD-1 therapy.
Hiroshi Sasaki, Junji Kato, Kohei Horimoto, Sayuri Sato, Yuna Hosokawa

J Dermatol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difference in immunohistochemical findings among anti-PD-L1 antibodies and their relationships with CD4+ and CD8+ T cells in Japanese melanoma patients.
Daisuke Yoneta, Junji Kato, Takafumi Kamiya, Kohei Horimoto, Sayuri Sato

Int J Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of programmed cell death ligand 1 (PD-L1) at in situ and invasive extramammary Paget's disease and literature review.
Junji Kato, Shintaro Sugita, Kohei Horimoto, Sayuri Sato, Daisuke Yoneta

Australas J Dermatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK-positive atypical Spitz tumour with conspicuous rosette-like structures.
Tomoyuki Minowa, Tokimasa Hida, Kohei Horimoto, Junji Kato, Takafumi Kamiya

Eur J Dermatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of neuron-specific enolase as a serum marker of metastatic melanoma.
Sayuri Sato, Junji Kato, Masahide Sawada, Kohei Horimoto, Masae Okura

J Dermatol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis